Valuation : TransMedics Group, Inc.

Market Cap 3.2B 2.74B 2.58B 2.35B 4.44B 305B 4.46B 30.49B 11.81B 154B 12.01B 11.75B 510B P/E 2026 *
66.2x
P/E 2027 * 41.9x
Enterprise Value 3.16B 2.71B 2.54B 2.32B 4.38B 301B 4.41B 30.1B 11.67B 152B 11.86B 11.6B 503B EV / Sales 2026 *
4.26x
EV / Sales 2027 * 3.49x
Free-Float
96.36%
Yield 2026 *
-
Yield 2027 * -
1 day-1.47%
1 week-1.86%
Current month+20.53%
1 month+27.62%
3 months+30.88%
6 months-31.47%
Current year-24.19%
1 week 90.24
Extreme 90.24
95.18
1 month 68
Extreme 68
95.18
Current year 60.1
Extreme 60.105
151.85
1 year 60.1
Extreme 60.105
156
3 years 36.42
Extreme 36.4201
177.37
5 years 10
Extreme 10
177.37
10 years 10
Extreme 10
177.37
Manager TitleAgeSince
Chief Executive Officer 57 01/08/1998
Director of Finance/CFO 55 02/12/2024
Chief Operating Officer 43 02/02/2023
Director TitleAgeSince
Director/Board Member 57 01/08/1998
Chairman 81 01/01/2011
Director/Board Member 78 01/02/2016
Date Insider Type Main position Quantity % Market Cap.
17/08/26 Don

Chairman

-18,000 0.0528%
10/07/26 Free

Chief Financial Officer

43,399 0.1273%
10/07/26 Free

Chief Operating Officer

29,511 0.0866%
Change 5-day change 1-year change 3-year change Capi.($)
-1.47%-1.86%-19.93%+47.53% 3.2B
+0.89%+3.29%+29.73%+17.01% 234B
-0.28%+1.83%+4.42%-15.72% 151B
-0.38%-6.86%-21.90%+24.49% 131B
-3.39%-7.38%-54.72%-5.10% 69.81B
-0.10%-1.63%+11.70%+19.18% 52.33B
-1.34%-2.69%-17.91%-15.32% 50.91B
+0.20%-0.21%+31.09%+29.58% 43.8B
-0.07%-0.40%+39.86%+51.51% 40.69B
-0.38%+2.19%-17.35%+46.41% 34B
Average -0.62%-0.15%-1.50%+19.96% 81.13B
Weighted average by Cap. -0.25%-0.05%+3.67%+12.08%

Financials

2026 *2027 *
Net sales 742M 637M 598M 546M 1.03B 70.74B 1.03B 7.07B 2.74B 35.69B 2.78B 2.72B 118B 875M 751M 705M 644M 1.21B 83.43B 1.22B 8.34B 3.23B 42.09B 3.28B 3.21B 139B
Net income 51.99M 44.62M 41.88M 38.25M 72.19M 4.96B 72.54M 496M 192M 2.5B 195M 191M 8.29B 89.08M 76.46M 71.76M 65.54M 124M 8.5B 124M 849M 329M 4.29B 334M 327M 14.2B
Net Debt -40.26M -34.55M -32.43M -29.62M -55.9M -3.84B -56.17M -384M -149M -1.94B -151M -148M -6.42B -146M -125M -117M -107M -202M -13.89B -203M -1.39B -538M -7.01B -547M -535M -23.21B
Logo TransMedics Group, Inc.
TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.
Employees
898
Date Price Change Volume
26/08/26 $92.22 -1.47% 448,872
25/08/26 $93.60 0.00% 405,438
24/08/26 $93.60 -1.23% 770,374
21/08/26 $94.77 +4.31% 628,723
20/08/26 $90.85 -3.32% 589,598
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
92.22USD
Average target price
97.30USD
Spread / Average Target
+5.51%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TMDX Stock